Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxyquinoline is a heterocyclic phenol and derivative of quinoline with antiseptic, disinfectant, and pesticide properties. It is primarily used as a biocidal component in over-the-counter products to inhibit abnormal biological growth in the vagina and restore natural pH. Oxyquinoline acts as a biocide to eliminate bacteria and fungi; however, its precise mechanism of action remains unknown. It has also been used as a stabilizer for hydrogen peroxide in cosmetic products and serves as a reagent and metal chelator. In pharmaceutical applications, it is found in combination vaginal gels for restoring acidity[1][3][5]. Oxyquinoline is also the ligand component of indium In-111 oxyquinoline (oxine), which is used diagnostically for radiolabeling autologous leukocytes[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oxyquinoline.